These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study. Wigal SB, Nordbrock E, Adjei AL, Childress A, Kupper RJ, Greenhill L. CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989 [Abstract] [Full Text] [Related]
67. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder. Gumustas F, Yilmaz I, Yulaf Y, Gokce S, Sabuncuoglu O. J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851 [Abstract] [Full Text] [Related]
69. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders]. Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M. Neuropsychiatr; 2007 Jun; 21(3):187-206. PubMed ID: 17915180 [Abstract] [Full Text] [Related]
70. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ, Schumacher E. J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):649-57. PubMed ID: 7775360 [Abstract] [Full Text] [Related]
71. [Transcranial magnetic stimulation in child and adolescent psychiatry: excitability of the motor system in tic disorders and/or attention deficit hyperactivity disorders]. Moll GH, Heinrich H, Rothenberger A. Z Kinder Jugendpsychiatr Psychother; 2001 Nov; 29(4):312-23. PubMed ID: 11763610 [Abstract] [Full Text] [Related]
73. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. Arch Gen Psychiatry; 1999 Sep; 56(9):842-7. PubMed ID: 12884890 [Abstract] [Full Text] [Related]
74. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):246-56. PubMed ID: 2016229 [Abstract] [Full Text] [Related]
76. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Int J Neuropsychopharmacol; 2002 Jun; 5(2):121-9. PubMed ID: 12135536 [Abstract] [Full Text] [Related]
77. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder. Wigal SB, Gupta S, Heverin E, Starr HL. J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428 [Abstract] [Full Text] [Related]
78. Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder. Fine S, Johnston C. Child Psychiatry Hum Dev; 1993 Jun; 24(1):25-30. PubMed ID: 8404241 [Abstract] [Full Text] [Related]